WINNIPEG, MANITOBA--(Marketwire - May 30, 2008) - Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today announced it received a letter from the American Stock Exchange (“Amex”) stating that the Amex has determined that Medicure is not in compliance with certain continued listing standards, as set forth in Part 10 of the Amex Company Guide (the “Company Guide”), and therefore has become subject to the procedures and requirements of Section 1009 of the Company Guide.
